-- 西班牙石油天然气生产商雷普索尔(Repsol)的下游业务已显露出温和的复苏迹象。RBC周五在一份研究报告中指出,其炼油指标平均为每桶10.90美元,接近2025年第四季度的水平,这一数字主要受3月份强劲业绩的提振。 RBC表示,4月份迄今为止,炼油利润率波动较大,但平均为每桶11.50美元,扣除包括运输在内的所有可变成本后,这一水平远低于市场整体利润率。 RBC指出,这可能反映了原油现货价差以及原油定价与成品油定价之间的时差。RBC还提到,过去一周左右,他们收到了几家美国炼油商(尤其是埃克森美孚(XOM))发布的“混乱”的第一季度业绩更新。 分析师预测,由于馏分油库存紧张,炼油利润率在2026年和2027年将持续高于周期中期水平,雷普索尔有望从中受益。 上游产量与RBC的预期相比“令人失望”,尽管受到一些一次性事件的影响。 RBC将第一季度上游盈利预期从3.39亿欧元下调至3.34亿欧元(3.904亿美元),工业盈利预期从6.06亿欧元下调至5.3亿欧元。 第一季度调整后净利润预计为9.85亿欧元,低于此前的10.9亿欧元,RBC的预期比市场普遍预期低2%。 RBC还修订了其商品价格预测报告,目前预测今明两年油价将上涨,并将布伦特原油长期价格预期从之前的每桶70美元上调至每桶80美元。分析师表示,伊朗冲突可能导致库存减少,从而支撑炼油利润率,而雷普索尔的股价通常与这些利润率走势一致。 加拿大皇家银行(RBC)表示,预计2026年炼油利润率将保持强劲,并预测雷普索尔2027年的自由现金流收益率将达到11%。 RBC预计,雷普索尔将推迟原计划于下半年进行的上游业务IPO,直到有更确凿的证据表明石油市场在中期内将保持强劲。 RBC表示,中东战争持续时间延长会增加全球经济衰退的风险,进而对雷普索尔构成需求侧风险。 RBC将雷普索尔的目标股价从之前的29欧元上调至32欧元,并维持对该公司的“跑赢大盘”评级。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.